NCT07509827 Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)
| NCT ID | NCT07509827 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | HIV Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2024-08-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.
Eligibility Criteria
Inclusion Criteria: * Age 18-29 years * Male sex at birth * Self-identify as transgender woman/female spectrum * HIV-negative (laboratory confirmed) * Recent condomless sex * Able to understand Thai * Not on PrEP or poorly adherent (≤3 pills/week) Exclusion Criteria: * Serious cognitive or psychiatric condition affecting consent * Active suicidal ideation or major mental illness * Medical contraindications to PrEP * Enrolled in another HIV intervention study
Contact & Investigator
Nittaya Phanuphak, MD,PhD.
PRINCIPAL INVESTIGATOR
INSTITUTE OF HIV RESEARCH AND INNOVATION FOUNDATION
Frequently Asked Questions
Who can join the NCT07509827 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 29 Years, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07509827 currently recruiting?
Yes, NCT07509827 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT07509827 trial being conducted?
This trial is being conducted at Bangkok, Thailand, Bangkok, Thailand, Bangkok, Thailand.
Who is sponsoring the NCT07509827 clinical trial?
NCT07509827 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Nittaya Phanuphak, MD,PhD. at INSTITUTE OF HIV RESEARCH AND INNOVATION FOUNDATION. The trial plans to enroll 108 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.